Leibniz Institute for Plasma Research and Technology
The Leibniz Institute for Plasma Science and Technology e.V. (INP) is the largest non-university research institution on low-temperature plasmas in Europe and ranks among the world leaders in this field. In addition to application-oriented basic research, the institute develops plasma-based processes and products in direct cooperation with industry and engages in innovation transfer through its own five spin-offs - true to the motto: "From the idea to the prototype". INP is organized as a non-profit association and has been a member of the Leibniz Association (https://www.leibniz-gemeinschaft.de/en/) since its foundation.
Derzeit stehen in zwei Forschungsbereichen Plasmen für Materialien und Energie sowie Umwelt und Gesundheit im Mittelpunkt der wissenschaftlichen Arbeit des INP.
The research area "Environment and Health" is focused on future markets in the life science sector. The main research areas are: Bioactive Surfaces, Plasma Medicine and Decontamination. The close cooperation of physicists, biologists, chemists, pharmacists, physicians and engineers with highly specialized technicians and laboratory staff is unique in the world.
The research focus "Plasma Medicine" deals with an innovative research field at the interface between physics and life sciences, which has been experiencing an immense international upswing for several years. So-called cold atmospheric pressure plasmas are generated with the aid of special plasma devices in order to achieve medical effects directly on or in the patient. Currently, the main field of application is the treatment of chronic, infected wounds and pathogen-related skin diseases.
Plasma can be used to inactivate many types of microorganisms including multi-resistant bacteria such as MRSA. In addition, clinical studies demonstrate that plasma supports natural wound healing by stimulating new tissue formation, thereby enhancing the healing process of poorly healing chronic wounds. Recent research results also indicate a possible benefit in the inactivation of tumor cells with longer or more intensive plasma treatments. This raises hopes for new perspectives in cancer treatment.
„The INP has been active in the interdisciplinary field between physics and medicine for about 20 years and has been successful with several spin-offs. We are looking forward to collaborate with the new Helmholtz Institute for One Health in the fields of life and environmental sciences.“
Prof. Klaus-Dieter Weltmann
Chairman of the Board and Scientific Director of the Leibniz Institute for Plasma Research and Technology e.V. (INP)